#USA #Frisco, Texas #AllyGPO #Oklahoma Cancer Specialists #AllyIQ

Transforming Oncology Care through Innovative Solutions

In a groundbreaking collaboration, AllyGPO®, a leading specialty group purchasing organization, and the Oklahoma Cancer Specialists and Research Institute (OCSRI) have demonstrated significant enhancements in member value and operational efficiency. This partnership showcases the power of modernized approaches to healthcare procurement, shifting beyond traditional group purchasing frameworks.

Based in Frisco, Texas, AllyGPO has established itself as a leading innovator, emphasizing technology and data-driven strategies in healthcare. OCSRI, a physician-owned network of specialists with over 40 professionals, provides extensive cancer care services tailored to meet the needs of Oklahomans. The alliance between these two entities is centered around enhancing the quality of cancer treatment through an efficient, evidence-based approach.

Modernizing Oncology Practices

OCSRI’s transition to AllyGPO in June 2025 was motivated by the necessity to modernize drug management practices and operational functions. This change arose from their experience with conventional GPOs, which often lacked transparency and adaptability in a rapidly evolving medical landscape. Brian Ansay, CEO of AllyGPO, expressed pride in this partnership, emphasizing its commitment to delivering data-driven insights and intelligent tools to positively impact frontline cancer care.

The implementation of AllyGPO’s AI-powered practice intelligence platform, known as AllyIQ®, has resulted in remarkable operational improvements for OCSRI. The following milestones highlight the progress made:

1. 35-Day Improvement in Rebate Payment Timing: Through enhanced manufacturer contracts and advanced contract management tools, OCSRI now experiences faster and more reliable rebate payments, directly benefiting their operating capital.
2. 99% Performance Visibility Against Estimated Rebate Opportunity: With comprehensive tracking of rebate performance, OCSRI has gained better clarity to refine drug management strategies proactively.
3. 75% Reduction in Drug Ordering Time: AI-enabled intelligent ordering streamlines administrative processes, allowing practitioners to focus more on clinical care rather than bureaucratic tasks.
4. 10% Reduction in Inventory Days on Hand: An innovative demand-based ordering system has optimized the management of high-cost oncology drug inventories, unlocking capital previously tied up in supplies.
5. 99% Drug Audit Accuracy: Improved visibility and automated workflows via the AllyIQ inventory management system have enabled OCSRI to achieve unprecedented accuracy in drug reconciliation processes.

Comprehensive Data Integration

AllyIQ is designed to unify clinical, operational, and financial data, affording teams the ability to make rapid decisions based on real-time insights. Tara Hallum, CFO of OCSRI, praised this tool, stating it has provided a level of intelligence and visibility not previously experienced. This enhanced oversight facilitates timely and informed decision-making across both clinical and business operations.

The collaboration exemplifies a growing trend towards independent practices in community oncology exploring alternatives to traditional GPO models that often restrict innovation and transparency. The strategic partnership with BioCareSD further amplifies OCSRI's operational improvements by enhancing the drug distribution model with high-touch service and transparent contracting. This approach is critical in navigating the increasingly complex specialty drug market dominated by large corporations.

The Future of Oncology Care

Looking ahead, AllyGPO and OCSRI continue to seek novel ways to minimize administrative burdens and bolster practice economics via advanced technology and data-driven methods. As community oncology evolves, this partnership stands as an example of how innovation can lead to improved patient care, operational effectiveness, and overall organizational health.

AllyGPO remains committed to delivering premium services tailored to the needs of independent practices, reshaping the future of specialty healthcare with actionable insights and technology-driven solutions. By focusing on sustainability and performance enhancements, they aim to empower practices like OCSRI in delivering top-tier cancer care.

For more information on this transformative partnership and its impact on oncology care, visit AllyGPO and Oklahoma Cancer Specialists and Research Institute.